-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$46.5873.94% Upside
Recent Analyst Forecasts and Stock Ratings
IDEAYA Biosciences, Inc. Frequently Asked Questions
-
What analysts cover IDEAYA Biosciences, Inc.?
IDEAYA Biosciences, Inc. has been rated by research analysts at Leerink Partners, UBS, Mizuho Securities, Goldman Sachs, Stifel Nicolaus, BTIG in the past 90 days.